SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 15, 2026

VCEL

Vericel Corp
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

The insider selling is too small to warrant a directional read. Monitor for any larger cluster (>0.5% of market cap) or C-suite open-market buying to gauge management conviction.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$34.87
T+0 close · May 15, 2026 · via day close
Latest settled
+28.28%
T+60 · $44.73
Vs SPY
+23.43%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $34.87entry
  2. T+1 · 6mo ago −1.09%α −0.44% · $34.49
  3. T+5 · 6mo ago +0.29%α −1.33% · $34.97
  4. T+20 · 5mo ago +10.30%α +8.71% · $38.46
  5. T+60 · 3mo ago +28.28%α +23.43% · $44.73

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vericel Corp insiders sold ~$459K in open-market transactions over the past week, representing a trivial 0.027% of the $1.7B market cap. The sales follow a strong Q1 earnings beat and raised guidance, but the dollar amount is immaterial and likely reflects routine post-earnings profit-taking or option exercise-related selling, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$459.0K
Insiders
4

Key Facts

  • Four insider sales totaling ~$459K: Director McLaughlin ($115K), Director Wotton ($83K), CFO Mara ($203K), PAO Siegal ($58K).
  • Sales represent only 0.027% of Vericel's $1.7B market cap, well below the 0.1% materiality threshold.
  • Occurred 4–8 days after Vericel reported Q1 2026 revenue of $68.4M (+30% YoY, beat consensus) and raised FY2026 guidance to $326-336M.

Financial Impact

Total insider sales of ~$459K, negligible vs. $1.7B market cap.

dilution

Risk Factors

  • Further insider selling at elevated volume could signal waning confidence.
  • Stock may be sensitive to upcoming quarterly results and MACI growth trajectory.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-VCEL-1778875982331

Track record

30 reports on VCEL

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +31.08% at T+60 after the May 7, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 1/10 Entry $57.42 Now $57.48 +0.10% settles Feb 10
  4. Nov 10, 20266d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  6. Nov 9, 20267d ago 144 Neutral 3/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  7. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
  8. Nov 6, 202610d ago 144 Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $54.62 Now $57.48 +5.24% settles Feb 4
Showing 10 of 30

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026